Detalles de la búsqueda
1.
Development of a portable mini-generator to safely produce nitric oxide for the treatment of infants with pulmonary hypertension.
Nitric Oxide
; 75: 70-76, 2018 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29486304
2.
Detection and removal of impurities in nitric oxide generated from air by pulsed electrical discharge.
Nitric Oxide
; 60: 16-23, 2016 11 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-27592386
3.
The effect of a semi-permeable, strengthening fiber coating on the expansion, mechanical properties, and residence time of gastroretentive fibrous dosage forms.
Int J Pharm
; 642: 122378, 2023 Jul 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-36464110
4.
Expandable, dual-excipient fibrous dosage forms for prolonged delivery of sparingly-soluble drugs.
Int J Pharm
; 615: 120396, 2022 Mar 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33716100
5.
Mechanical strength and gastric residence time of expandable fibrous dosage forms.
Int J Pharm
; 613: 120792, 2022 Feb 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34363914
6.
Expandable fibrous dosage forms for prolonged drug delivery.
Mater Sci Eng C Mater Biol Appl
; 120: 110144, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-33545806
7.
Solid-solution fibrous dosage forms for immediate delivery of sparingly-soluble drugs: Part 2. 3D-micro-patterned dosage forms.
Mater Sci Eng C Mater Biol Appl
; 129: 110211, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34579874
8.
The role of excipient molecular weight in drug release by fibrous dosage forms with close packing and high drug loading.
Int J Pharm
; 606: 120009, 2021 Sep 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33246051
9.
Solid-solution fibrous dosage forms for immediate delivery of sparingly-soluble drugs: Part 1. Single fibers.
Mater Sci Eng C Mater Biol Appl
; 109: 109918, 2020 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-32228997
10.
WITHDRAWN: Gastroretentive fibrous dosage forms for prolonged delivery of sparingly-soluble tyrosine kinase inhibitors. Part 1: Dosage form design, and models of expansion, post-expansion mechanical strength, and drug release.
Int J Pharm
; 653: 123428, 2024 Mar 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-37806505
11.
WITHDRAWN: Gastroretentive fibrous dosage forms for prolonged delivery of sparingly soluble tyrosine kinase inhibitors. Part 3: Theoretical models of in vivo expansion, gastric residence time, and drug concentration in blood.
Int J Pharm
; 653: 123478, 2024 Mar 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-37839493
12.
WITHDRAWN: Gastroretentive fibrous dosage forms for prolonged delivery of sparingly soluble tyrosine kinase inhibitors. Part 2: Experimental validation of the models of expansion, mechanical strength, and in vitro drug release.
Int J Pharm
; 653: 123429, 2024 Mar 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-37805149
13.
Withdrawal notice to: "Gastroretentive fibrous dosage forms for prolonged delivery of sparingly-soluble tyrosine kinase inhibitors. Part 1: Dosage form design, and models of expansion, post-expansion mechanical strength, and drug release" [Int. J. Pharm. 653 (2024) 123428].
Int J Pharm
; 653: 124019, 2024 03 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-38521689
14.
Withdrawal notice to: "Gastroretentive fibrous dosage forms for prolonged delivery of sparingly-soluble tyrosine kinase inhibitors. Part 4: Experimental validation of the models of in vivo expansion, gastric residence time, and drug concentration in blood" [Int. J. Pharm. 653 (2024) 123479].
Int J Pharm
; 653: 124022, 2024 03 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-38521691
15.
Withdrawal notice to: "Gastroretentive fibrous dosage forms for prolonged delivery of sparingly soluble tyrosine kinase inhibitors. Part 2: Experimental validation of the models of expansion, mechanical strength, and in vitro drug release" [Int. J. Pharm. 653 (2024) 123429].
Int J Pharm
; 653: 124020, 2024 03 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-38521692
16.
Withdrawal notice to: "Gastroretentive fibrous dosage forms for prolonged delivery of sparingly soluble tyrosine kinase inhibitors. Part 3: Theoretical models of in vivo expansion, gastric residence time, and drug concentration in blood" [Int. J. Pharm. 653 (2024) 123478].
Int J Pharm
; 653: 124021, 2024 03 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-38521690
17.
WITHDRAWN: Gastroretentive fibrous dosage forms for prolonged delivery of sparingly-soluble tyrosine kinase inhibitors. Part 4: Experimental validation of the models of in vivo expansion, gastric residence time, and drug concentration in blood.
Int J Pharm
; 653: 123479, 2024 Mar 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-37838099
18.
Fibrous dosage forms by wet 3D-micro-patterning: Process design, manufacture, and drug release rate.
Eur J Pharm Biopharm
; 130: 345-358, 2018 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-29932976
19.
3D-micro-patterned fibrous dosage forms for immediate drug release.
Mater Sci Eng C Mater Biol Appl
; 84: 218-229, 2018 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29519432
20.
Microstructural effects in drug release by solid and cellular polymeric dosage forms: A comparative study.
Mater Sci Eng C Mater Biol Appl
; 80: 715-727, 2017 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28866221